The $6 Billion Shot at Making New Antibiotics—Before the Old Ones Fail
Antimicrobials cost as much to develop as other drugs, but [...]
Forge Therapeutics awarded up to $17.2 million by NIH/NIAID for FG-LpxC, a novel antibiotic to treat antimicrobial resistance (AMR)
San Diego, California, September 29, 2022 – Forge Therapeutics, [...]